Abolishing ß-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists (2023)

First Author: Hinds C
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dom.15288

PubMed Identifier: 37795639

Publication URI: http://europepmc.org/abstract/MED/37795639

Type: Journal Article/Review

Parent Publication: Diabetes, Obesity and Metabolism

Issue: 1

ISSN: 1462-8902